Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
An Open-Label, Safety Study for Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy
Sponsor: PTC Therapeutics
Listed as NCT01247207, this PHASE3 trial focuses on Duchenne Muscular Dystrophy and remains completed. Sponsored by PTC Therapeutics, it has been updated 50 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
50 versions recorded-
Mar 2026 — Present [monthly]
Completed PHASE3
Status: Enrolling By Invitation → Completed
-
Sep 2025 — Mar 2026 [monthly]
Enrolling By Invitation PHASE3
-
May 2025 — Sep 2025 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2025 — May 2025 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2025 — Apr 2025 [monthly]
Enrolling By Invitation PHASE3
▶ Show 45 earlier versions
-
Dec 2024 — Feb 2025 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2024 — Dec 2024 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2024 — Nov 2024 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Enrolling By Invitation PHASE3
-
May 2024 — Jul 2024 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2024 — May 2024 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2024 — Apr 2024 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2023 — Feb 2024 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2023 — Dec 2023 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2023 — Oct 2023 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2023 — Mar 2023 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2022 — Dec 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2022 — Jul 2022 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2022 — Jun 2022 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2022 — Apr 2022 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2021 — Feb 2022 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2021 — Dec 2021 [monthly]
Enrolling By Invitation PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2021 — Jun 2021 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2021 — Apr 2021 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2021 — Mar 2021 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE3
-
Oct 2020 — Dec 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2020 — Oct 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Enrolling By Invitation PHASE3
-
May 2020 — Jun 2020 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2020 — May 2020 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2020 — Mar 2020 [monthly]
Enrolling By Invitation PHASE3
-
Nov 2019 — Jan 2020 [monthly]
Enrolling By Invitation PHASE3
-
Aug 2019 — Nov 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2019 — Aug 2019 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2019 — Jun 2019 [monthly]
Enrolling By Invitation PHASE3
-
Dec 2018 — Apr 2019 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2018 — Dec 2018 [monthly]
Enrolling By Invitation PHASE3
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE3
-
Jun 2017 — May 2018 [monthly]
Enrolling By Invitation PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Enrolling By Invitation PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE3
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- PTC Therapeutics
For direct contact, visit the study record on ClinicalTrials.gov .